Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Stock
Equities
002864
CNE1000032C9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.39 CNY | +0.23% | +2.25% | -31.44% |
Sales 2022 | 974M 134M | Sales 2023 | 981M 135M | Capitalization | 4.05B 557M |
---|---|---|---|---|---|
Net income 2022 | 101M 13.89M | Net income 2023 | 110M 15.13M | EV / Sales 2022 | 3 x |
Net cash position 2022 | 396M 54.5M | Net cash position 2023 | 999M 137M | EV / Sales 2023 | 3.11 x |
P/E ratio 2022 |
33.2
x | P/E ratio 2023 |
34.1
x | Employees | 864 |
Yield 2022 |
0.52% | Yield 2023 |
0.57% | Free-Float | 57.68% |
1 day | +0.23% | ||
1 week | +2.25% | ||
Current month | +1.97% | ||
1 month | -9.47% | ||
3 months | -11.29% | ||
6 months | -31.44% | ||
Current year | -31.44% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Xie
CEO | Chief Executive Officer | 56 | 13-06-15 |
Feng Ming Zhu
DFI | Director of Finance/CFO | 53 | 13-06-15 |
Jie Wu
BRD | Director/Board Member | 54 | 13-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Hong Zhang
BRD | Director/Board Member | 60 | 13-06-15 |
Jie Wu
BRD | Director/Board Member | 54 | 13-06-15 |
Xiao Lin Xie
CEO | Chief Executive Officer | 56 | 13-06-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 26.39 | +0.23% | 983,700 |
24-07-01 | 26.33 | +1.74% | 1,238,900 |
24-06-28 | 25.88 | -0.27% | 1,310,500 |
24-06-27 | 25.95 | -1.78% | 985,200 |
24-06-26 | 26.42 | +2.09% | 1,049,200 |
End-of-day quote Shenzhen S.E., July 01, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.44% | 381M | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 002864 Stock